|1||Active, not recruiting||
Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer
|2||Active, not recruiting||
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
|3||Active, not recruiting||
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
† Study has passed its completion date and status has not been verified in more than two years.